BHFAP — Brighthouse Financial, Inc.

Brighthouse Financial (BHFAP) Q2 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Earnings: $198 million, or $3.43 per share, down from $245 million in Q1 2025 and $346 million in Q2 2024.
• Combined Risk-Based Capital (RBC) Ratio: Estimated between 405% and 425%, within the target range of 400% to 450%.
• Total Adjusted Capital (TAC): Approximately $5.6 billion, up from $5.5 billion in Q1 2025, driven by a decline in variable annuity (VA) and Shield reserves.
• Annuity Sales: $2.6 billion, a 16% sequential increase and 8% year-over-year increase; Shield sales contributed $1.9 billion.
• Life Insurance Sales: $33 million for the quarter, totaling $69 million year-to-date, a 21% increase compared to the same period in 2024.
• Corporate Expenses: $202 million, down from $239 million in Q1 2025 and slightly up from $200 million in Q2 2024.

2. Strategic Updates and Business Highlights

• Continued execution of capital-focused strategic initiatives aimed at improving capital efficiency and managing risk.
• Successful sales performance in annuities and life insurance, with a notable contribution from the BlackRock LifePath Paycheck product, which generated $176 million in deposits.
• Ongoing revisions to the hedging strategy for both in-force variable annuity and Shield business to enhance capital management.
• Shareholder returns included $43 million in common stock repurchases, totaling $102 million year-to-date.

3. Forward Guidance and Outlook

• The company remains focused on maintaining a strong capital position and executing strategic initiatives, with expectations for continued sales growth.
• Anticipated completion of the revised hedging strategy by the end of September 2025, which is expected to enhance capital management and reduce volatility.
• No specific guidance on long-term free cash flow projections, likely deferred to 2026.

4. Bad News, Challenges, or Points of Concern

• Adjusted earnings fell significantly below quarterly average run rate expectations due to lower alternative investment income and underwriting margins, with a yield of only 1.5% on the alternative investment portfolio.
• Increased claims severity in both Life and Run-off segments, with severity reported at 18% above normal levels, raising concerns about underwriting performance.
• Shield sales experienced a decline for the first time in several years, attributed to increased competition and the challenges of growing off a large base.
• The unassigned surplus in the Delaware Reinsurance Company remains negative at around $2 billion, which may complicate future cash distributions.

5. Notable Q&A Insights

• Management emphasized the importance of the ongoing actuarial review and its potential implications for statutory results, but no specific updates were provided.
• The transition to a separated hedging strategy is expected to simplify management and reduce volatility, although the immediate capital impact is not anticipated to be significant.
• The company remains committed to returning capital to shareholders through stock buybacks, although recent repurchase activity has paused.
• Management acknowledged competitive pressures in the annuity market but expressed confidence in maintaining pricing discipline and operational capabilities.
• Concerns were raised about the adequacy of cash flow projections relative to market conditions, with management indicating that they would address these in future updates.

Overall, Brighthouse Financial reported strong sales and maintained a solid capital position, but faced challenges with earnings volatility and increased claims severity, alongside competitive pressures in the annuity market.